Phosphatidylinositol-(4,5)-bisphosphate enables efficient secretion of HIV-1 Tat by infected T-cells

EMBO Journal

Volumn 29, Issue 8, 2010, Pages 1348-1362

  Rayne, Fabienne ^a,g   Debaisieux, Solène ^a,g   Yezid, Hocine ^a   Lin, Yea Lih ^b   Mettling, Clément ^b   Konate, Karidia ^c   Chazal, Nathalie ^a   Arold, Stefan T ^d   Pugnière, Martine ^a   Sanchez, Françoise ^a   Bonhoure, Anne ^a   Briant, Laurence ^a   Loret, Erwann ^e   Roy, Christian ^f   Beaumelle, Bruno ^a  

^a University of Montpellier I and II   (France)

^b INSTITUTE OF HUMAN GENETICS   (France)

^c Centre National de la Recherche Scientifique   (France)

^d INSERM   (France)

^e AIX MARSEILLE UNIVERSITY   (France)

^f UNIVERSITÉ DE MONTPELLIER   (France)

^g UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

HIV 1; PIP2; Tat; Toxin; Unconventional secretion

Indexed keywords

PHOSPHATIDYLINOSITOL (4,5) BISPHOSPHATE; PHOSPHOLIPID; TRANSACTIVATOR PROTEIN; TRYPTOPHAN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CD4+ T LYMPHOCYTE; CELL MEMBRANE; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LEUKEMIA CELL LINE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SECRETION;

BINDING SITES; CD4-POSITIVE T-LYMPHOCYTES; CELL MEMBRANE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV-1; HUMANS; JURKAT CELLS; PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE; PROTEIN BINDING; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77951498245     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1038/emboj.2010.32     Document Type: Article

References (62)

1. Aharonovitz O, Zaun HC, Balla T, York JD, Orlowski J, Grinstein S (2000) Intracellular pH regulation by Na(+)/H(+) exchange requires phosphatidylinositol 4,5-bisphosphate. J Cell Biol 150: 213-224
2. Astoul E, Edmunds C, Cantrell DA, Ward SG (2001) PI 3-K and T-cell activation: limitations of T-leukemic cell lines as signaling models. Trends Immunol 22: 490-496
3. Barret C, Roy C, Montcourrier P, Mangeat P, Niggli V (2000) Mutagenesis of the phosphatidylinositol 4,5-bisphosphate (PIP(2)) binding site in the NH(2)-terminal domain of ezrin correlates with its altered cellular distribution. J Cell Biol 151: 1067-1080
4. Bayer P, Kraft M, Ejchart A, Westendorp M, Frank R, Rosch P (1995) Structural studies of HIV-1 Tat protein. J Mol Biol 247: 529-535
5. Blin G, Margeat E, Carvalho K, Royer CA, Roy C, Picart C (2008) Quantitative analysis of the binding of ezrin to large unilamellar vesicles containing phosphatidylinositol(4,5)-bisphosphate. Biophys J 94: 1021-1033
6. Botelho RJ, Teruel M, Dierckman R, Anderson R, Wells A, York JD, Meyer T, Grinstein S (2000) Localized biphasic changes in phosphatidylinositol-4,5- bisphosphate at sites of phagocytosis. J Cell Biol 151: 1353-1368
7. Brown FD, Rozelle AL, Yin HL, Balla T, Donaldson JG (2001) Phosphatidylinositol 4,5-bisphosphate and Arf6-regulated membrane traffic. J Cell Biol 154: 1007-1017
8. Caputo GA, London E (2003) Using a novel dual fluorescence quenching assay for measurement of tryptophan depth within lipid bilayers to determine hydrophobic alpha-helix locations within membranes. Biochemistry 42: 3265-3274
9. Chan R, Uchil PD, Jin J, Shui G, Ott DE, Mothes W, Wenk MR (2008) Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides. J Virol 82: 11228-11238
10. Chang HC, Samaniego F, Nair BC, Buonaguro L, Ensoli B (1997) HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. AIDS 11:1421-1431
11. Chertova E, Chertov O, Coren LV, Roser JD, Trubey CM, Bess Jr JW, Sowder II RC, Barsov E, Hood BL, Fisher RJ, Nagashima K, Conrads TP, Veenstra TD, Lifson JD, Ott DE (2006) Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macro-phages. J Virol 80: 9039-9052
12. Chiu YL, Ho CK, Saha N, Schwer B, Shuman S, Rana TM (2002) Tat stimulates cotranscriptional capping of HIV mRNA. Mol Cell 10: 585-597
13. Corbin JA, Dirkx RA, Falke JJ (2004) GRP1 pleckstrin homology domain: activation parameters and novel search mechanism for rare target lipid. Biochemistry 43: 16161-16173
14. De Matteis MA, Godi A (2004) PI-loting membrane traffic. Nat Cell Biol 6: 487-492
15. Di Paolo G, De Camilli P (2006) Phosphoinositides in cell regulation and membrane dynamics. Nature 443: 651-657
16. Dupont E, Prochiantz A, Joliot A (2007) Identification of a signal peptide for unconventional secretion. J Biol Chem 282: 8994-9000
17. Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, Wong-Staal F (1990) Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345: 84-86
18. Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelman R, Morgan RA, Wingfield P, Gallo RC (1993) Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 67: 277-287
19. Gallo RC (1999) Tat as one key to HIV-induced immune pathogen-esis and Tat toxoid as an important component of a vaccine. Proc Natl Acad Sci USA 96: 8324-8326
20. Ghezzi S, Noonan DM, Aluigi MG, Vallanti G, Cota M, Benelli R, Morini M, Reeves JD, Vicenzi E, Poli G, Albini A (2000) Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat. Biochem Biophys Res Commun 270: 992-996
21. Helland DE, Welles JL, Caputo A, Haseltine WA (1991) Transcellular transactivation by the human immunodeficiency virus type 1 tat protein. J Virol 65: 4547-4549
22. Heo WD, Inoue T, Park WS, Kim ML, Park BO, Wandless TJ, Meyer T (2006) PI(3,4,5)P3 and PI(4,5)P2 lipids target proteins with polybasic clusters to the plasma membrane. Science 314: 1458-1461
23. Holz RW, Hlubek MD, Sorensen SD, Fisher SK, Balla T, Ozaki S, Prestwich GD, Stuenkel EL, Bittner MA (2000) A pleckstrin homology domain specific for phosphatidylinositol 4, 5-bispho-sphate (PtdIns-4,5-P2) and fused to green fluorescent protein identifies plasma membrane PtdIns-4,5-P2 as being important in exocytosis. J Biol Chem 275: 17878-17885
24. Honing S, Ricotta D, Krauss M, Spate K, Spolaore B, Motley A, Robinson M, Robinson C, Haucke V, Owen DJ (2005) Phosphatidylinositol-(4,5)-bisphosphate regulates sorting signal recognition by the clathrin-associated adaptor complex AP2. Mol Cell 18: 519-531
25. Huang L, Bosch I, Hofmann W, Sodroski J, Pardee AB (1998) Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains. J Virol 72: 8952-8960
26. Huigen MC, Kamp W, Nottet HS (2004) Multiple effects of HIV-1 trans-activator protein on the pathogenesis of HIV-1 infection. Eur J Clin Invest 34: 57-66
27. Jeang KT, Xiao H, Rich EA (1999) Multifaceted activities of the HIV-1 transactivator of transcription, Tat. J Biol Chem 274: 28837-28840
28. Joliot A, Prochiantz A (2004) Transduction peptides: from technology to physiology. Nat Cell Biol 6: 189-196
29. Jost M, Simpson F, Kavran JM, Lemmon MA, Schmid SL (1998) Phosphatidylinositol-4,5-bisphosphate is required for endocytic coated vesicle formation. Curr Biol 8: 1399-1402
30. Keller M, Ruegg A, Werner S, Beer HD (2008) Active caspase-1 is a regulator of unconventional protein secretion. Cell 132: 818-831
31. Lemmon MA (2003) Phosphoinositide recognition domains. Traffic 4: 201-213
32. Lemmon MA, Ferguson KM, O'Brien R, Sigler PB, Schlessinger J (1995) Specific and high-affinity binding of inositol phosphates to an isolated pleckstrin homology domain. Proc Natl Acad Sci USA 92: 10472-10476
33. Marasco WA, Szilvay AM, Kalland KH, Helland DG, Reyes HM, Walter RJ (1994) Spatial association of HIV-1 tat protein and the nucleolar transport protein B23 in stably transfected Jurkat T-cells. Arch Virol 139: 133-154
34. Marcello A, Cinelli RA, Ferrari A, Signorelli A, Tyagi M, Pellegrini V, Beltram F, Giacca M (2001) Visualization of in vivo direct interaction between HIV-1 TAT and human cyclin T1 in specific subcellular compartments by fluorescence resonance energy transfer. J Biol Chem 276: 39220-39225
35. Marcuzzi A, Weinberger J, Weinberger OK (1992) Transcellular activation of the human immunodeficiency virus type 1 long terminal repeat in cocultured lymphocytes. J Virol 66: 4228-4232
36. Maroun CR, Naujokas MA, Park M (2003) Membrane targeting of Grb2-associated binder-1 (Gab1) scaffolding protein through Src myristoylation sequence substitutes for Gab1 pleckstrin homology domain and switches an epidermal growth factor response to an invasive morphogenic program. Mol Biol Cell 14: 1691-1708
37. McLaughlin S, Wang J, Gambhir A, Murray D (2002) PIP(2) and proteins: interactions, organization, and information flow. Annu Rev Biophys Biomol Struct 31: 151-175
38. Méré J, Morlon-Guyot J, Bonhoure A, Chiche L, Beaumelle B (2005) Acid-triggered membrane insertion of pseudomonas exotoxin A involves an original mechanism based on pH-regulated trypto-phan exposure. J Biol Chem 280: 21194-21201
39. Nickel W, Rabouille C (2009) Mechanisms of regulated unconventional protein secretion. Nat Rev Mol Cell Biol 10: 148-155
40. Ono A, Ablan SD, Lockett SJ, Nagashima K, Freed EO (2004) Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc Natl Acad Sci USA 101: 14889-14894
41. Pantano S, Carloni P (2005) Comparative analysis of HIV-1 Tat variants. Proteins 58: 638-643
42. Pendaries C, Tronchere H, Arbibe L, Mounier J, Gozani O, Cantley L, Fry MJ, Gaits-Iacovoni F, Sansonetti PJ, Payrastre B (2006) PtdIns5P activates the host cell PI3-kinase/Akt pathway during Shigella flexneri infection. EMBO J 25: 1024-1034
43. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD (1996) HIV-1 dynamics in vivo: virion clearance rate, infected cell life span, and viral generation time. Science 271: 1582-1586
44. Ranki A, Lagerstedt A, Ovod V, Aavik E, Krohn KJ (1994) Expression kinetics and subcellular localization of HIV-1 regulatory proteins Nef, Tat and Rev in acutely and chronically infected lymphoid cell lines. Arch Virol 139: 365-378
45. Rubartelli A, Poggi A, Sitia R, Zocchi MR (1998) HIV-I Tat: a polypeptide for all seasons. Immunol Today 19: 543-545
46. Sivakumaran H, van der Horst A, Fulcher AJ, Apolloni A, Lin MH, Jans DA, Harrich D (2009) Arginine methylation increases the stability of human immunodeficiency virus type 1 Tat. J Virol 83: 11694-11703
47. Stahelin RV, Long F, Peter BJ, Murray D, De Camilli P, McMahon HT, Cho W (2003) Contrasting membrane interaction mechanisms of AP180 N-terminal homology (ANTH) and epsin N-terminal homology (ENTH) domains. J Biol Chem 278: 28993-28999
48. Stauber RH, Pavlakis GN (1998) Intracellular trafficking and interactions of the HIV-1 Tat protein. Virology 252: 126-136
49. Stebbing J, Gazzard B, Douek DC (2004) Where does HIV live? N Engl J Med 350: 1872-1880
50. Stephens L, Anderson K, Stokoe D, Erdjument-Bromage H, Painter GF, Holmes AB, Gaffney PR, Reese CB, McCormick F, Tempst P, Coadwell J, Hawkins PT (1998) Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate- dependent activation of protein kinase B. Science 279: 710-714
51. Temmerman K, Ebert AD, Muller HM, Sinning I, Tews I, Nickel W (2008) A direct role for phosphatidylinositol-4,5-bisphosphate in unconventional secretion of fibroblast growth factor 2. Traffic 9: 1204-1217
52. Truant R, Cullen BR (1999) The arginine-rich domains present in human immunodeficiency virus type 1 Tat and Rev function as direct importin beta-dependent nuclear localization signals. Mol Cell Biol 19: 1210-1217
53. Varnai P, Balla T (1998) Visualization of phosphoinositides that bind pleckstrin homology domains: calcium-and agonist-induced dynamic changes and relationship to myo-[3H]inositol-labeled phosphoinositide pools. J Cell Biol 143: 501-510
54. Vendeville A, Rayne F, Bonhoure A, Bettache N, Montcourrier P, Beaumelle B (2004) HIV-1 Tat enters T-cells using coated pits before translocating from acidified endosomes and eliciting biological responses. Mol Biol Cell 15: 2347-2360
55. Walker BD, Burton DR (2008) Toward an AIDS vaccine. Science 320: 760-764
56. Watt SA, Kular G, Fleming IN, Downes CP, Lucocq JM (2002) Subcellular localization of phosphatidylinositol 4,5-bisphosphate using the pleckstrin homology domain of phospholipase C delta1. Biochem J 363: 657-666
57. Weiss JM, Nath A, Major EO, Berman JW (1999) HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes. J Immunol 163: 2953-2959
58. White SH, Wimley WC (1999) Membrane protein folding and stability: physical principles. Annu Rev Biophys Biomol Struct 28: 319-365
59. Xiao H, Neuveut C, Tiffany HL, Benkirane M, Rich EA, Murphy PM, Jeang KT (2000) Selective CXCR4 antagonism by tat: implications for in vivo expansion of coreceptor use by HIV-1. Proc Natl Acad Sci USA 97: 11466-11471
60. Yezid H, Konate K, Debaisieux S, Bonhoure A, Beaumelle B (2009) Mechanism for HIV-1 TAT insertion into the endosome membrane. J Biol Chem 284: 22736-22746
61. Zhang J, Tamilarasu N, Hwang S, Garber ME, Huq I, Jones KA, Rana TM (2000) HIV-1 TAR RNA enhances the interaction between Tat cyclin T1. J Biol Chem 275: 34314-34319
62. Zimmermann P, Meerschaert K, Reekmans G, Leenaerts I, Small JV, Vandekerckhove J, David G, Gettemans J (2002) PIP(2)-PDZ domain binding controls the association of syntenin with the plasma membrane. Mol Cell 9: 1215-1225